← FDA Drug Approvals (Drugs@FDA)
ABEMACICLIB
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: QILU PHARMACEUTICAL CO., LTD. · Approved 2025-11-06
Drug application
- FDA Application #
ANDA220238- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ABEMACICLIB
- Generic name
- Abemaciclib
- Active ingredients
- ABEMACICLIB
- Dosage form
- TABLET
- Route
- —
- Marketing status
- None (Tentative Approval)
- Sponsor
- QILU PHARMACEUTICAL CO., LTD.
- First approval
- 2025-11-06
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown